ARCT Message Board Post 10926380 | Arcturus Therapeutics...
home / stock / arct / arct message board
(investorshangout)
Posted on: Aug/02/2021 14:30:51
Source: investorshangout
https://investorshangout.com/post/view?id=6203423
whytestocks: $ARCT News Article - Arcturus Announces Approval of a Clinical Trial Application to Advance ARCT-154
News, Short Squeeze, Breakout and More Instantly...
Arcturus Therapeutics Ltd. Company Name:
ARCT Stock Symbol:
Market:
Arcturus Therapeutics Ltd. Website:
-
2024-07-02 10:15:03 ET Piper Sandler analyst issues OVERWEIGHT recommendation for ARCT on July 2, 2024 08:19AM ET. The previous analyst recommendation was Overweight. ARCT was trading at $23.66 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
-
ARCT-810 Phase 2 study completed enrollment at 0.3 mg/kg dose level in Europe with data expected later this year ARCT-810 to expand Phase 2 clinical program in the U.S. to enroll patients with more severe disease ARCT-032 IND for Phase 2 multiple ascending dose study to be submitt...
-
Previously Chief Scientific Advisor for Operation Warp Speed, advised U.S. President's Council of Advisors on Science and Technology, member of Advisory Committee to the Director of the NIH Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasda...